Experimental Hematology
Volume 37, Issue 11 , Pages 1353-1363 , November 2009

Antiplatelet antibodies in WASP(−) mice correlate with evidence of increased in vivo platelet consumption

  • Bindumadhav M. Marathe

      Affiliations

    • Department of Pathology and Laboratory Medicine, University of Tennessee Health Sciences Center, Memphis, Tenn., USA
    • ,
  • Amanda Prislovsky

      Affiliations

    • Department of Pathology and Laboratory Medicine, Memphis Veterans Administration Medical Center, Memphis, Tenn., USA
    • ,
  • Alexander Astrakhan

      Affiliations

    • Seattle Children's Hospital Research Institute, Seattle, Wash., USA
    • ,
  • David J. Rawlings

      Affiliations

    • Seattle Children's Hospital Research Institute, Seattle, Wash., USA
    • Department's of Pediatrics and Immunology, University of Washington School of Medicine, Seattle, Wash., USA
    • ,
  • Jim Y. Wan

      Affiliations

    • Department of Preventive Medicine, University of Tennessee Health Sciences Center, Memphis, Tenn., USA
    • ,
  • Ted S. Strom

      Affiliations

    • Department of Pathology and Laboratory Medicine, University of Tennessee Health Sciences Center, Memphis, Tenn., USA
    • Department of Pathology and Laboratory Medicine, Memphis Veterans Administration Medical Center, Memphis, Tenn., USA
    • Corresponding Author InformationOffprint requests to: Ted S. Strom, M.D., Ph.D., Department of Pathology and Laboratory Medicine, Memphis VA Medical Center, 1030 Jefferson Avenue, Memphis, TN 38104

Received 10 July 2009 ,Revised 10 August 2009 ,Accepted 27 August 2009.

References 

  1. Baldini MG. Nature of the platelet defect in the Wiskott-Aldrich syndrome. Ann N Y Acad Sci. 1972;201:437–444
  2. Grottum KA, Hovig T, Holmsen H, Abrahamsen AF, Jeremic M, Seip M. Wiskott-Aldrich syndrome: qualitative platelet defects and short platelet survival. Br J Haematol. 1969;17:373–388
  3. Ochs HD, Slichter SJ, Harker LA, Von Behrens WE, Clark RA, Wedgwood RJ. The Wiskott-Aldrich syndrome: studies of lymphocytes, granulocytes, and platelets. Blood. 1980;55:243–252
  4. Hanson SR, Slichter SJ. Platelet kinetics in patients with bone marrow hypoplasia: evidence for a fixed platelet requirement. Blood. 1985;66:1105–1109
  5. Kajiwara M, Nonoyama S, Eguchi M, et al. WASP is involved in proliferation and differentiation of human haemopoietic progenitors in vitro. Br J Haematol. 1999;107:254–262
  6. Luthi JN, Gandhi MJ, Drachman JG. X-linked thrombocytopenia caused by a mutation in the Wiskott-Aldrich syndrome (WAS) gene that disrupts interaction with the WAS protein (WASP)-interacting protein (WIP). Exp Hematol. 2003;31:150–158
  7. Sabri S, Foudi A, Boukour S, et al. Deficiency in the Wiskott-Aldrich protein induces premature proplatelet formation and platelet production in the bone marrow compartment. Blood. 2006;108:134–140
  8. Dupuis-Girod S, Medioni J, Haddad E, et al. Autoimmunity in Wiskott-Aldrich syndrome: risk factors, clinical features, and outcome in a single-center cohort of 55 patients. Pediatrics. 2003;111:e622–e627
  9. Humblet-Baron S, Sather B, Anover S, et al. Wiskott-Aldrich syndrome protein is required for regulatory T cell homeostasis. J Clin Invest. 2007;117:407–418
  10. Mullen C, Anderson KD, Blaese RM. Splenectomy and/or bone marrow transplantation in the management of the Wiskott-Aldrich syndrome: long-term followup of 52 cases. Blood. 1993;82:2961–2966
  11. Notarangelo LD, Mazza C, Giliani S, et al. Missense mutations of the WASP gene cause intermittent X-linked thrombocytopenia. Blood. 2002;99:2268–2269
  12. Corash L, Shafer B, Blaese RM. Platelet-associated immunoglobulin, platelet size, and the effect of splenectomy in the Wiskott-Aldrich syndrome. Blood. 1985;65:1439–1443
  13. Kanegane H, Nomura K, Miyawaki T, et al. X-linked thrombocytopenia identified by flow cytometric demonstration of defective Wiskott-Aldrich syndrome protein in lymphocytes. Blood. 2000;95:1110–1111
  14. Litzman J, Jones A, Hann I, Chapel H, Strobel S, Morgan G. Intravenous immunoglobulin, splenectomy, and antibiotic prophylaxis in Wiskott-Aldrich syndrome. Arch Dis Child. 1996;75:436–439
  15. Semple JW, Siminovitch KA, Mody M, et al. Flow cytometric analysis of platelets from children with the Wiskott-Aldrich syndrome reveals defects in platelet development, activation and structure. Br J Haematol. 1997;97:747–754
  16. Prislovsky A, Marathe B, Hosni A, et al. Rapid platelet turnover in WASP(-) mice correlates with increased ex vivo phagocytosis of opsonized WASP(-) platelets. Exp Hematol. 2008;36:609–623
  17. Mizutani H, Engelman RW, Kurata Y, Ikehara S, Good RA. Development and characterization of monoclonal antiplatelet autoantibodies from autoimmune thrombocytopenic purpura-prone (NZW x BXSB)F1 mice. Blood. 1993;82:837–844
  18. Snapper SB, Rosen FS, Mizoguchi E, et al. Wiskott-Aldrich syndrome protein-deficient mice reveal a role for WASP in T but not B cell activation. Immunity. 1998;9:81–91
  19. Kitamura D, Roes J, Kuhn R, Rajewsky KA. B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene. Nature. 1991;350:423–426
  20. Ault KA, Rinder HM, Mitchell J, Carmody MB, Vary CP, Hillman RS. The significance of platelets with increased RNA content (reticulated platelets). A measure of the rate of thrombopoiesis. Am J Clin Pathol. 1992;98:637–646
  21. George JN. Platelet immunoglobulin G: its significance for the evaluation of thrombocytopenia and for understanding the origin of alpha-granule proteins. Blood. 1990;76:859–870
  22. Olsson M, Bruhns P, Frazier WA, Ravetch JV, Oldenborg PA. Platelet homeostasis is regulated by platelet expression of CD47 under normal conditions and in passive immune thrombocytopenia. Blood. 2005;105:3577–3582
  23. Nimmerjahn F, Ravetch JV. Divergent immunoglobulin g subclass activity through selective Fc receptor binding. Science. 2005;310:1510–1512
  24. Oldenborg PA. Role of CD47 in erythroid cells and in autoimmunity. Leuk Lymphoma. 2004;45:1319–1327
  25. Gross BS, Wilde JI, Quek L, Chapel H, Nelson DL, Watson SP. Regulation and function of WASp in platelets by the collagen receptor, glycoprotein VI. Blood. 1999;94:4166–4176
  26. Rengan R, Ochs HD, Sweet LI, et al. Actin cytoskeletal function is spared, but apoptosis is increased, in WAS patient hematopoietic cells. Blood. 2000;95:1283–1292
  27. Falet H, Hoffmeister KM, Neujahr R, Hartwig JH. Normal Arp2/3 complex activation in platelets lacking WASp. Blood. 2002;100:2113–2122
  28. Andreansky S, Liu CH, Turner SJ, et al. WASP- mice Exhibit Defective Immune Responses to Influenza A Virus, Streptococcus pneumoniae, and Mycobacterium bovis BCG. Exp Hematol. 2005;33:443–451
  29. Birks JW, Klassen LW, Gurney CW. Hypoxia-induced thrombocytopenia in mice. J Lab Clin Med. 1975;86:230–238
  30. McDonald TP, Clift RE, Cottrell MB. Large, chronic doses of erythropoietin cause thrombocytopenia in mice. Blood. 1992;80:352–358
  31. Santoso S, Zimmermann U, Neppert J, Mueller-Eckhardt C. Receptor patching and capping of platelet membranes induced by monoclonal antibodies. Blood. 1986;67:343–349
  32. White JG, Escolar G. Induction of receptor clustering, patching, and capping on surface-activated platelets. Lab Invest. 1990;63:332–340
  33. Hezard N, Simon G, Mace C, Jallu V, Kaplan C, Nguyen P. Is flow cytometry accurate enough to screen platelet autoantibodies?. Transfusion. 2008;48:513–518

PII: S0301-472X(09)00359-2

doi: 10.1016/j.exphem.2009.08.007

Experimental Hematology
Volume 37, Issue 11 , Pages 1353-1363 , November 2009

Article Tools

* Image Usage & Resolution